Skip to main content
. 2023 Mar 14;11(3):658. doi: 10.3390/vaccines11030658

Figure 3.

Figure 3

Shows the addition of a SORT lipid molecule to typical four-component LNPs alters the in vivo delivery profile of the resultant five-component SORT LNPs, allowing for tissue-specific distribution of mRNA to the liver, lungs, and spleen of mice following IV injections.